Home > Newsfeed
Anna Azvolinsky - May 2016
According to a new study published in Cancer, cognitive behavioral therapy may help reduce long-term memory problems linked to chemotherapy treatment in cancer survivors. In the study, cognitive behavioral therapy, delivered via videoconferencing, was able to reduce cognitive impairments, according to participants self-reports. These results suggest this non-invasive therapy as a way for cancer survivors to manage one of the self-reported negative effects of cancer treatment.
Dr. Robert Ferguson, of the University of Pittsburgh Cancer Institute, along with colleagues, developed the Memory and Attention Adaptation Training (MAAT). This is a type of cognitive behavioral therapy specifically designed to treat patients with chemotherapy-related cognitive dysfunction (CRCD).
For the full story, click here.
Original source: www.cancernetwork.com